Effect of Stellate Ganglion Block on Insomnia
The Effect of Stellate Ganglion Block on Insomnia Patients: a Pre - and Post Control Experiments
This study tests if a procedure called Stellate Ganglion Block can help people with chronic insomnia sleep better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | People's Hospital of Zhengzhou University Academic / other |
| Locations | 1 site (Seoul) |
| Trial ID | NCT06255730 on ClinicalTrials.gov |
What this trial studies
This study evaluates the impact of Stellate Ganglion Block on patients suffering from insomnia. It involves administering the Stellate Ganglion Block procedure to participants who meet specific criteria for chronic insomnia. The quality of sleep will be assessed to determine if this intervention can lead to improvements in sleep patterns and overall well-being. The study aims to provide insights into a potential new treatment for insomnia.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 who have been diagnosed with chronic insomnia and have not used insomnia medications for at least four weeks.
Not a fit: Patients with severe cardiovascular or pulmonary diseases, mental disorders, or those currently participating in other clinical trials may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve sleep quality for patients suffering from chronic insomnia.
How similar studies have performed: While the use of Stellate Ganglion Block for insomnia is a novel approach, similar interventions have shown promise in treating other conditions, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Insomnia patients with the ages over 18. * Meeting the diagnostic criteria for chronic insomnia as per the International Classification of Sleep Disorders (ICSD) or the Diagnostic and Statistical Manual of Mental Disorders (DSM). * Experiencing insomnia symptoms persistently for at least three months. * Not currently using or ceased using medication for insomnia for at least four weeks. * Willing to undergo Stellate Ganglion Block treatment and participate in the study. Exclusion Criteria: * Patients with severe cardiovascular disease, pulmonary disease, or other serious physical health issues. * Pregnant or lactating women. * Patients with mental disorders (such as major depression, anxiety disorders, schizophrenia, etc.) or cognitive impairments. * Patients with known allergies or contraindications to Stellate Ganglion Block treatment. * Patients currently participating in other clinical trials or receiving experimental treatments.
Where this trial is running
Seoul
- Center Rehabilitation Hospital — Seoul, Korea, Republic of (Recruiting)
Study contacts
- Study coordinator: Qianyun Lu, Master
- Email: luqianyun@126.com
- Phone: 15333866454
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.